These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1230 related items for PubMed ID: 15883636

  • 1. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB.
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [Abstract] [Full Text] [Related]

  • 2. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH.
    Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
    [Abstract] [Full Text] [Related]

  • 3. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [Abstract] [Full Text] [Related]

  • 4. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, Glass EV, Myers SL, Krege JH.
    J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
    [Abstract] [Full Text] [Related]

  • 5. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 6. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC, Rosen CJ, Chen P, Misurski DA, Marcus R.
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [Abstract] [Full Text] [Related]

  • 7. PINP as an aid for monitoring patients treated with teriparatide.
    Tsujimoto M, Chen P, Miyauchi A, Sowa H, Krege JH.
    Bone; 2011 Apr 01; 48(4):798-803. PubMed ID: 21168536
    [Abstract] [Full Text] [Related]

  • 8. Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.
    Eastell R, Krege JH, Chen P, Glass EV, Reginster JY.
    Curr Med Res Opin; 2006 Jan 01; 22(1):61-6. PubMed ID: 16393431
    [Abstract] [Full Text] [Related]

  • 9. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A, Glover SJ, Eastell R.
    Bone; 2009 Dec 01; 45(6):1044-52. PubMed ID: 19665601
    [Abstract] [Full Text] [Related]

  • 10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 01; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 11. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 12. Relationship of bone turnover to bone density and fractures.
    Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL.
    J Bone Miner Res; 1997 Jul 15; 12(7):1083-91. PubMed ID: 9200008
    [Abstract] [Full Text] [Related]

  • 13. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul 15; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

  • 14. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
    Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher JC, Pavo I, Wang J, Eriksen EF.
    J Clin Endocrinol Metab; 2005 Jul 15; 90(7):3970-7. PubMed ID: 15840739
    [Abstract] [Full Text] [Related]

  • 15. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.
    McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF.
    Arch Intern Med; 2005 Jul 15; 165(15):1762-8. PubMed ID: 16087825
    [Abstract] [Full Text] [Related]

  • 16. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
    Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM, John MR.
    Bone; 2009 Dec 15; 45(6):1053-8. PubMed ID: 19679211
    [Abstract] [Full Text] [Related]

  • 17. Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment.
    Watts NB, Miller PD, Kohlmeier LA, Sebba A, Chen P, Wong M, Krohn K.
    J Bone Miner Res; 2009 Jun 15; 24(6):1125-31. PubMed ID: 19113918
    [Abstract] [Full Text] [Related]

  • 18. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    J Bone Miner Metab; 2005 Jun 15; 23(3):238-42. PubMed ID: 15838627
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun 15; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 20. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
    Cosman F, Nieves J, Woelfert L, Shen V, Lindsay R.
    J Bone Miner Res; 1998 Jun 15; 13(6):1051-5. PubMed ID: 9626638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.